In Brazil there are limited knowledge and education about preventative exercises for pelvic floor muscles (PFMs). We hypothesised that a single pelvic floor muscle exercise (PFME) session immediately postpartum would be effective in preventing urinary incontinence (UI) in a 3-month postpartum period with good adherence rates. Two hundred two women were approached for this randomised […]
To assess the efficacy and safety profile of the Adjustable Trans-Obturator Male System (ATOMS) for post-prostatectomy incontinence (PPI) in a multi-centered North American setting. We reviewed outcomes from 8 centers in men undergoing treatment for PPI with ATOMS. Primary outcomes were pad change and continence (defined as requiring ≤1.0 pad postoperatively for patients requiring ≥2.0 […]
Introduction: Robot-assisted laparoscopic radical prostatectomy (RALRP) is now considered the standard treatment for localized prostate cancer. However, challenges may arise when dealing with large prostates with a prominent median lobe because the ureteral orifices may not always be visible during dissection and maybe injured in the process.
Although relatively rare, vesicovaginal fistula is the most common genitourinary fistula, causing a significant decrease in patients’ quality of life. Location of fistula is major supratrigonal, with some cases located in the trigone and rarely below it.
Although relatively rare, vesicovaginal fistula is the most common genitourinary fistula, causing a significant decrease in patients’ quality of life. Location of fistula is major supratrigonal, with some cases located in the trigone and rarely below it.
Introduction: Robot-assisted laparoscopic radical prostatectomy (RALRP) is now considered the standard treatment for localized prostate cancer. However, challenges may arise when dealing with large prostates with a prominent median lobe because the ureteral orifices may not always be visible during dissection and maybe injured in the process.
Forkhead box A1 (FOXA1) is a pioneer transcription factor that is essential for the normal development of several endoderm-derived organs, including the prostate gland1,2. FOXA1 is frequently mutated in hormone-receptor-driven prostate, breast, bladder and salivary-gland tumours3-8. However, it is unclear how FOXA1 alterations affect the development of cancer, and FOXA1 has previously been ascribed both […]
Bladder cancer (BCa) is ninth amongst the most common types of cancer in the human population worldwide. The statistics of incidence and mortality of BCa are alarming and the currently applied diagnostic methods are still not sensitive enough. This leads to a large number of undiagnosed BCa cases, usually among patients in the early stages […]
The Bladder Cancer Advocacy Network (BCAN) Patient Survey Network identified pain during intravesical procedures as a research priority for patients. Although intraurethral lidocaine is standard of care in this setting, evidence for its use is equivocal. We performed a systematic review of studies evaluating interventions to reduce discomfort during cystoscopy and intravesical therapies for bladder […]
Intravesical BCG is a highly effective treatment for high-grade nonmuscle invasive bladder cancer and carcinoma in situ (CIS); however, for patients who are either resistant or become unresponsive to BCG therapy there is a need for alternative treatment approaches. This study examined the safety and feasibility of intravesically administered recombinant fowlpox virus encoding GM-CSF (Arm […]
